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background:  Currently, there is no method to predict if a patient dies, the likelihood that the death will be a sudden death (potentially 
preventable with an ICD) vs. a non sudden death. We tested the concept that a patient a higher estimated proportion of sudden death, with 
a similar annual mortality, will derive more benefit from an ICD than a similar patient with a lower estimated proportion of sudden death (i.e. 
70% vs. 40% proportion sudden death).
Methods:  We developed the Seattle Proportional Risk Model (SPRM) to predict the proportion of death that is due to sudden death 
in 9,985 patients without ICDs (Val-HeFT, PRAISE, Italian HF Registry, COMET, and University of Washington) using age, gender, EF, 
NYHA, SBP, Na, Cr, digoxin use, BMI, and diabetes. We prospectively tested this model in the patients enrolled in MADIT II with the 8 year 
F/U data with censoring for ICD crossover, to determine the extent to which ICD benefit for all-cause mortality would vary based on the 
predicted proportional risk of sudden death. The Seattle Heart Failure Model was used to adjust for heart failure severity.
results:  The mean predicted proportion of sudden death for the SPRM quartiles was 42%, 55%, 63%, and 74%. During the initial 20 
months of the trial, the risk of VT/VF shock increased with increasing SPRM quartile; 15%, 14%, 20%, and 23%. In a Cox proportional 
hazards model, the ICD benefit for all-cause mortality was 22%, (HR 0.78; P=0.005). However, the ICD benefit varied with the SPRM with 
greater benefit of the ICD in patients with a higher predicted proportion of sudden death (interaction p=0.03). The ICD hazard ratios for low 
to higher risk SPRM quartiles was 0.92, 0.72, 0.76, and 0.66.
Conclusion:  Although a primary prevention ICD in MADIT II during 8 year F/U reduced all cause mortality by 22%, the benefit is not 
uniform. In MADIT-II, the reduction in all cause mortality was confined to those with a higher proportional risk of sudden death as predicted 
by SPRM of (>51%), whereas patients in the lowest quartile of SPRM risk had no mortality benefit from the ICD (≤51%). The SPRM can be 
a real-time tool to identify individuals who are most appropriate for a primary prevention ICD.
